Compare CAAS & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CAAS | ORMP |
|---|---|---|
| Founded | N/A | 2002 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 130.6M | 134.1M |
| IPO Year | N/A | 2010 |
| Metric | CAAS | ORMP |
|---|---|---|
| Price | $4.16 | $3.32 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 27.3K | ★ 164.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.61% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.26 |
| Revenue | N/A | ★ $1,340,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $3.97 | ★ $2.61 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.50 | $1.82 |
| 52 Week High | $5.37 | $3.76 |
| Indicator | CAAS | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 39.42 | 48.48 |
| Support Level | $4.13 | $3.22 |
| Resistance Level | $4.40 | $3.76 |
| Average True Range (ATR) | 0.15 | 0.20 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 25.00 | 28.57 |
China Automotive Systems Inc is a holding company. The firm through its subsidiary is a supplier of power steering systems and components to China's automotive industry. Its product offering encompasses a full range of auto parts incorporated into steering systems for both passenger automobiles and commercial vehicles. The company offers four separate series, models of power steering including rack and pinion power steering, integral power steering, electronic power steering and manual steering, steering columns, steering oil pumps, and steering hoses. Geographically, it derives a majority of its revenue from China.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.